Lindsay Peglar Marsala

Medicine & Life Sciences

1. Myotonic Dystrophy 100%
2. Subdural Hematoma 98%
3. White Matter 70%
4. Patient Care 59%
5. Newborn Infant 59%
6. Wounds and Injuries 54%
7. Magnetic Resonance Imaging 51%
8. Pregnancy 46%
9. Intracranial Hemorrhages 34%
10. Child 33%
11. Nervous System 31%
12. Maternal Death 31%
13. Myasthenia Gravis 30%
14. Brain 24%
15. NFI Transcription Factors 22%
16. Intracranial Sinus Thrombosis 17%
17. Tomography 17%
18. Mothers 16%
19. Fibrinolytic Agents 15%
20. Urinary Tract 15%
21. Status Epilepticus 14%
22. Low Molecular Weight Heparin 14%
23. Platelet Aggregation Inhibitors 14%
24. Ketamine 14%
25. Cerebral Hemorrhage 13%
26. Hypothermia 13%
27. Cerebrovascular Disorders 13%
28. Trinucleotide Repeat Expansion 12%
29. Heart Arrest 12%
30. Disease Management 12%
31. Venous Thrombosis 12%
32. Cesarean Section 12%
33. Anticonvulsants 12%
34. Antihypertensive Agents 11%
35. Transcription Factors 11%
36. Thymine 11%
37. Brain Hypoxia-Ischemia 11%
38. Neuromuscular Diseases 10%
39. Induced Hypothermia 10%
40. Muscle Hypotonia 10%
41. Cytosine 10%
42. Guanine 10%
43. Seizures 10%
44. Emergencies 9%
45. Stroke 8%
46. Health Care Outcome Assessment 8%
47. Therapeutics 8%
48. Inborn Genetic Diseases 7%
49. Equipment and Supplies 7%
50. Morbidity 7%